Vigonvita Life Sciences
Clinical trials sponsored by Vigonvita Life Sciences, explained in plain language.
-
Meal timing matters: new study tests drug absorption after eating
Knowledge-focused Not yet recruitingThis early-stage study looks at how a high-fat meal or a standard meal changes the way the body absorbs a single dose of the drug VV913. Twelve healthy Chinese men will take the drug under different meal conditions to measure side effects and drug levels in the blood. The results…
Phase: PHASE1 • Sponsor: Vigonvita Life Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New drug VV913 gets first safety check in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage trial will test the safety and how the body handles a new drug called VV913. It involves 24 healthy Chinese men aged 18 to 45. Participants will receive either a low, medium, or high dose of VV913 or a placebo, and researchers will monitor side effects and drug l…
Phase: EARLY_PHASE1 • Sponsor: Vigonvita Life Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC